To include your compound in the COVID-19 Resource Center, submit it here.

Rilutek glutamate antagonist data

RPR (New York) announced that the drug shows an impact on survival in a preliminary analysis of

Read the full 179 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE